Skip to main content
Log in

Retrograde Closure of Perimembranous Ventricular Septal Defect Using Muscular Ventricular Septal Occluder: A Single-Center Experience of a Novel Technique

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

We herein report the advantages of retrograde ventricular septal defect (VSD) closure using a muscular VSD device for perimembranous VSDs. Perimembranous VSDs are conventionally closed by an antegrade technique (arteriovenous looping technique) using a patent ductus arteriosus or asymmetric perimembranous VSD device. However, we used a symmetrical muscular VSD device in all cases described in this report. Use of the antegrade technique for the first few patients with VSD resulted in prolonged procedural and fluoroscopic times and frequent slippage of the device into the right ventricle. Subsequent use of the retrograde technique shortened the procedural time and allowed for easier closure of the perimembranous VSD. We performed retrograde closure of perimembranous VSDs using a symmetrical muscular VSD device in 130 patients. We obtained a high rate of successful deployment (88.5 %) and a low rate of complications (6.0 %). We also achieved shorter procedural and fluoroscopic times than those associated with the antegrade technique.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Bass JL, Karla GS, Arora R et al (2003) Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv 58:238–245

    Article  PubMed  Google Scholar 

  2. Fu YC, Bass J, Amin Z et al (2006) Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder. Results of the U.S. phase I trial. J Am Coll Cardiol 47:319–325

    Article  PubMed  Google Scholar 

  3. Gu X, Han YM, Titus JL et al (2000) Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model. Catheter Cardiovasc Interv 50:502–509

    Article  CAS  PubMed  Google Scholar 

  4. Hijazi ZM, Hakim F, Abu Haweleh A et al (2002) Catheter closure of perimembranous ventricular septal defects using new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv 56:508–515

    Article  PubMed  Google Scholar 

  5. Holzer R, de Giovanni J, Walsh KP et al (2006) Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv 68:620–628

    Article  PubMed  Google Scholar 

  6. Kramoh E, Dahdah N, Fournier A et al (2008) Invasive measurements of atrioventricular conduction parameters prior to and following ventricular septal defect closure with the Amplatzer device. J Invasive Cardiol 20:212–216

    PubMed  Google Scholar 

  7. Masura J, Gao W, Gavora P et al (2005) Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow- up study. Pediatric Cardiol 26:216–219

    Article  CAS  Google Scholar 

  8. Miro J, Hosking M, Lee KJ, et al (2005) Closure of perimembranous ventricular septal defects with the Amplatzer device: multicenter Canadian experience. Pediatric interventional cardiac symposium and emerging new technologies in congenital heart surgery (PICS/ENTICHS-2005), Buenos Aires, 15–18 September 2005

  9. Pedra CAC, Pedra SRF, Esteves CA et al (2004) Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Catheter Cardiovasc Interv 61:403–410

    Article  PubMed  Google Scholar 

  10. Pinto RJ, Dalvi BV, Sharma S (2006) Transcatheter closure of perimembranous ventricular septal defects using Amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up. Catheter Cardiovasc Interv 68:145–152

    Article  PubMed  Google Scholar 

  11. Rigby ML, Redington AN (1994) Primary transcatheter closure of perimembranous ventricular septal defects. Br Heart J 72:368–371

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Thanopoulos BD, Rigby ML, Karanasios E et al (2007) Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder. Am J Cardiol 99:984–989

    Article  PubMed  Google Scholar 

  13. Yip WCL, Zimmerman F, Hijazi ZM (2005) Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect. Catheter Cardiovasc Interv 66:436–441

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kalyanasundaram Muthusamy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muthusamy, K. Retrograde Closure of Perimembranous Ventricular Septal Defect Using Muscular Ventricular Septal Occluder: A Single-Center Experience of a Novel Technique. Pediatr Cardiol 36, 106–110 (2015). https://doi.org/10.1007/s00246-014-0971-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-014-0971-x

Keywords

Navigation